P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpression

P J Coronado1, J A Vidart, J A Lopez-asenjo

  • 1Department of Obstetrics and Gynecology, Hospital Clínico San Carlos, Madrid, Spain. pcoronadom@sego.es

Abstract